Table 1 Detailed descriptions of included studies
Author (Year) | Surgery | Size (E/C) | Delivery way | Dose of steroid | Anesthesia | Country | Follow-up |
|---|---|---|---|---|---|---|---|
Koh et al. (2013)[12] | TKA | 269 (135/134) | IV | 10 mg DA before operation and further dose at end of operation (H) | SA | Korea | 1 year |
Fujii et al. (2005) [13] | TKA | 80 (20/20/20/20) | IV | 4 mg (L) or 8 mg (H) or 16 mg (H) DA at end of operation | GA or SA | Japan | Unclear |
Jules-Elysee et al. (2011) [14] | TKA | 30 (15/15) | IV | 100 mg HC before operation and futher dose at 8 h later (L) | SA | USA | 6 months |
McLawhorn et al. (2014) [15] | TKA | 23 (11/12) | IV | 100 mg HC before operation and followed by 2 doses each 8 h apart (H) | SA | USA | Unclear |
Jules-Elysee et al. (2012) [16] | TKA | 34 (17/17) | IV | 100 mg HC before operation and further dose at 8 h later (L) | SA | USA | 6 months |
Bergeron et al. (2009) [17] | THA | 50 (25/25) | IV | 40 mg DA before operation (H) | SA | Canada | 1 year |
Lunn et al. (2011) [20] | TKA | 48 (24/24) | IV | 125 mg MP before operation (H) | SA | Denmark | 1 month |
Backes et al. (2013) [21] | TKA/ THA | TKA:68 (28/25/20) THA:47 (13/17/17) | IV | E1: 10 mg DA before operation (H) E2: 10 mg DA before operation and further dose at 24 h later (H) | GA | USA | 6 months at least |
Sculco et al. (2015) [22] | THA | 27 (13/14) | PO + IV | 20 mg PD orally before operation, followed by 2 doses 100 mg HC intravenously each 8 h apart (H) | SA | USA | 3 months |
Lunn et al. (2013) [23] | THA | 48 (24/24) | IV | 125 mg MP before operation (H) | SA | Denmark | 1 month |
Kardash et al. (2007) [24] | THA | 50 (25/25) | IV | 40 mg DA before operation (H) | SA | Canada | 1 month |